Amaryllis Nucleics' Convertible Note Round

Amaryllis Nucleics raised a round of funding on March 25, 2016.

Amaryllis Nucleics is creating technology that reduces the time and cost of RNA sequencing in order to empower cancer diagnostics, pharmaceutical development, and food security innovations.…

Articles about Amaryllis Nucleics' Convertible Note Round: